Iris Research and Development

Plantation, Florida 33324

3 studies enrolling now · 13 studies all time

What they study most

Arthritis, Rheumatoid, Autoimmunity, Inflammation, Diffuse Cutaneous Systemic Sclerosis, Giant Cell Arteritis (GCA), Psoriatic Arthritis, Rheumatoid Arthritis, Rotator Cuff Tendinopathy, Scleroderma, Systemic, Symptomatic Knee Osteoarthritis, Systemic Lupus Erythematosus

Studies at this site

• Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis — Recruiting now
• A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Recruiting now
• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) — Running, not enrolling
• Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis — Running, not enrolling
• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) — Completed
• Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis — Completed
• Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy — Stopped early
• A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms — Completed
• Treatments Against RA and Effect on FDG-PET/CT — Completed
• Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) — Completed
• A Phase II Study of M2951 in SLE — Stopped early